Compound 7P

Compound 7P is an experimental small molecule discussed for sharper thinking and possible nerve repair. The practical record is sparse: subjective benefit claims sit beside unchanged experiences, uncertain amounts and unresolved safety questions. Feeling different does not show that nerves have regrown.

What it is and why people discuss it

• The nerve-growth research compound. This article concerns the sulfonamidoacetamide known as Compound 7P or Compound 7p, associated with CAS 1890208-58-8. It is a synthetic non-peptide; “7p” is a laboratory designation reused for unrelated molecules. Official context Animal context
• Repair is the hope. The Longecity opener asks about retinopathy and damage attributed to amphetamine abuse. These are questions, not recovery reports. Longecity
• Nerve extensions are not new neurons. The original study describes outgrowth from cultured nerve cells and axon regeneration in an animal optic-nerve injury model. An axon is a nerve cell’s signal-carrying extension; these findings do not demonstrate new human brain cells, restored vision or better memory. Animal context

What people report

• Feeling good is the clearest early Reddit claim. One commenter estimated 5–10 mg daily and felt good on day two, while questioning placebo and changing co-use. A specific cognitive benefit was not established. Reddit
• A learning claim includes tiredness. A newer NooTopics reply claims quicker learning with some tiredness. It gives no route, amount or learning test, and does not clearly document a personal trial; it is a claim worth distinguishing from a measured improvement. Reddit

How it compares with nearby nootropics

• Dihexa and Noopept are discussion neighbors. The Kimera-linked guide lists both beside Compound 7P. Their separate STUDresearch articles cover different identities and accounts; there is no head-to-head result here showing which improves learning, and no basis for transferring their dosing or timing to 7P. Community guide
• A stack list is not evidence of a working combination. The same guide names Semax, TAK-653 and choline products. It supplies no controlled comparison or individual combination log; the list establishes promotional framing, not demonstrated synergy or interaction safety. Community guide

Doses people discuss

• Oral: approximately 1 mg, later described as 2 mg or less twice daily. These are wholoman’s spoon estimates, not a measured range or separate users. Longecity
• 5–10 mg per day: one uncertain Reddit estimate. Route unstated; this daily estimate is not a usual amount or safe ceiling. Reddit
• 10 mg per capsule is a promotional label. The Kimera-linked guide advertises this strength. A product label is not human dosing evidence or proof of equivalent absorption across routes. Community guide

Half-life

• 1–2 hours is an unverified vendor claim repeated in discussion. Longecity attributes it to a manufacturer; no human clearance measurement is supplied. Longecity

Onset: when a change is noticed

• Day two in one account; no dependable onset window. The commenter’s day-two impression does not establish minutes-to-onset after one dose or a repair timeline. Reddit

Duration: how long a change lasts

• No supported single-dose duration. These accounts do not track a dose through a clear start and finish. Follow-up dates cannot supply effect duration. Reddit Reddit

Cycles and breaks

• Intermittent weeks are reported; a cycle is not established. Turnbuckle described intermittent use over weeks without noticeable effects. No reliable on/off calendar emerges. Longecity
• A follow-up can mean no further exposure. The sublingual experimenter later reported no further use. That establishes neither repeated-dose safety nor a useful cycle. Reddit

Good to know

• The insomnia account changed. Wholoman stopped after insomnia, then reported that co-used Hypoxen reproduced insomnia alone. Causation remains unresolved. Longecity
• Amounts and identity are uncertain. One experiment involved a malfunctioning scale. Survival after an unmeasured exposure establishes little about safety or the actual substance taken. Reddit
• Sparse reports cannot define the risks. There is no usable interaction map or long-term safety record in these sources. Community worries about cancer are not evidence that this compound causes cancer; promotional claims of mild side effects are not evidence that serious effects are absent. Reddit Community guide
• Animal findings do not settle human treatment questions. The research does not establish treatment of diabetic eye disease, stimulant-related injury or cognitive decline. It also does not establish absorption into the human brain from the routes described online. Animal context

What the community discussion adds

• Positive and null accounts coexist. Wholoman initially described sharper thinking. Moomoo noticed nothing sublingually; Turnbuckle likewise reported no effect. Neither null report measures nerve repair. Longecity
• Anhedonia is another question, not a demonstrated benefit. A newer commenter wants anecdotes before experimenting for persistent anhedonia and inflammation-linked symptoms. Interest in a difficult symptom is not a successful treatment account. Reddit
• Confident mechanism labels need identity checks. Reddit calls 7P a thromboxane antagonist without substantiation. The original nerve-growth study leaves its mechanism open. Reddit Animal context
• The Alzheimer’s link needs a different identity check. A newer reply links a paper whose title identifies pyranone-carbamate derivatives, a different series from this sulfonamidoacetamide. Its indexed title does not support transferring Alzheimer’s results to this Compound 7P; the full linked paper was inaccessible during this review. Reddit Official context